Sunday - April 20, 2025
Sterling Pharma USA Seeks DEA Approval for Bulk Manufacturing of Schedule I Substances
March 15, 2025
WASHINGTON, March 15 (TNSFR) -- Sterling Pharma USA LLC, based in Cary, North Carolina, has applied to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of several Schedule I controlled substances. The company is seeking approval to produce tetrahydrocannabinols, psilocybin, dimethyltryptamine, 5-methoxy-N,N-dimethyltryptamine, and psilocyn.

According to the DEA filing, Sterling Pharma USA intends to manufacture these substances to support internal re . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products